Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

Clicks: 359
ID: 269180
2006
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #34 of 105 articles by views in Antimicrobial agents and chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Influenza is a highly infectious disease characterized by recurrent annual epidemics and unpredictable major worldwide pandemics. Rapid spread of the highly pathogenic avian H5N1 strain and escalating human infections by the virus have set off the alarm for a global pandemic. To provide an urgently …
Reference Key
mp2006antimicrobialsialidase Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Malakhov MP;Aschenbrenner LM;Smee DF;Wandersee MK;Sidwell RW;Gubareva LV;Mishin VP;Hayden FG;Kim DH;Ing A;Campbell ER;Yu M;Fang F;;
Journal Antimicrobial agents and chemotherapy
Year 2006
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.